A Rare Pathological Phenotype of Endometrioid Serous and Clear-Cell Ovarian Cancer with PIK3CA Mutations in Relation to The Excellent Response of Alpelisib

A Rare Pathological Phenotype of Endometrioid Serous and Clear-Cell Ovarian Cancer with PIK3CA Mutations in Relation to The Excellent Response of Alpelisib

Patients with metastatic ovarian cancer who develop resistance to standard therapy with or without platinum need to search for other therapeutic choices. Therefore, identifying genetic alterations and selecting an approach to treatment using precision medicine techniques are important. In a patient...

Full description

Bibliographic Details
Main Authors: Ertugrul Bayram, Ghanim Khatib, Burak Guney, Emine Kilicbagir, Huru Rabia Gulec, Ibrahim Boga, Semra Paydas
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Genes
Subjects:
alpelisib
ovarian cancer
PI3K inhibitor
Online Access:https://www.mdpi.com/2073-4425/14/8/1632

Internet

https://www.mdpi.com/2073-4425/14/8/1632

Similar Items